1. Synergistic inhibitory effect of Smo inhibitor jervine and its combination with decitabine can target Hedgehog signaling pathway to inhibit myelodysplastic syndrome cell line
   Fang Zhao et al, 2021, Hematology CrossRef
2. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends
   Jamileh Kadkhoda et al, 2022, Life Sciences CrossRef
3. Total coumarins of Hedyotis diffusa induces apoptosis of myelodysplastic syndrome SKM-1 cells by activation of caspases and inhibition of PI3K/Akt pathway proteins
   Jianping Jiang et al, 2017, Journal of Ethnopharmacology CrossRef
4. Phytochemicals and PI3K Inhibitors in Cancer—An Insight
   Vasanti Suvarna et al, 2017, Frontiers in Pharmacology CrossRef
5. Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML
   Zhen Zhang et al, 2018, Oncology Letters CrossRef
6. MEK/ERK and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases
   Zhuanzhen Zheng et al, 2023, International Journal of Oncology CrossRef
7. Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells
   Si Hyoung Kim et al, 2016, Biomedicine & Pharmacotherapy CrossRef
8. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells
   WEI HE et al, 2016, International Journal of Oncology CrossRef
9. Network Pharmacology-Based Approach to Investigate the Mechanisms ofHedyotis diffusaWilld. in the Treatment of Gastric Cancer
   Xinkui Liu et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef